Compare VVOS & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | AMS |
|---|---|---|
| Founded | 2016 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 11.1M |
| IPO Year | 2020 | 1995 |
| Metric | VVOS | AMS |
|---|---|---|
| Price | $0.51 | $1.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 92.4K |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $17,443,000.00 | ★ $19,714,000.00 |
| Revenue This Year | $69.66 | $6.93 |
| Revenue Next Year | $48.38 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 16.05 | 0.81 |
| 52 Week Low | $0.49 | $1.25 |
| 52 Week High | $7.40 | $3.11 |
| Indicator | VVOS | AMS |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 48.55 |
| Support Level | N/A | $1.27 |
| Resistance Level | $0.76 | $1.75 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 5.98 | 61.54 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.